✦ LIBER ✦

Phase II study of weekly docetaxel (Taxotere; txt) and trastuzumab (Herceptin; H) for patients with HER-2 overexpressing (HER2+) metastatic breast cancer (MBC)

✍ Scribed by F.J. Esteva; V. Valero; D. Booser; L.T. Guerra; J.L. Murray; L. Pusztai; M. Cristofanilli; N. Sneige; T.L. Smith; G.N. Hortobagyi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

370 Primary treatment with weekly doceta

✍ J. Bines; A. Murad; S. Lago; B. Ferrari; J. Andrade; E. Abdo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Combination docetaxel and trastuzumab tr

✍ Nobuaki Sato; Muneaki Sano; Toshio Tabei; Taro Asaga; Jiro Ando; Hirofumi Fujii; 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 553 KB

Weekly docetaxel and trastuzumab for her

✍ S Takao; N Kohno; M Miyashita; I Kokufu; K Wakita 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 319 KB

A multinational phase II study of Navelb

✍ M Untch; S Kahlert; L Petruzelka; M Martin; V Guillem-Porta; M Gil; P Kellokumpu 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Weekly Gemcitabine and Trastuzumab in th

✍ Denise A. Yardley; Howard A. Burris III; Sarah Hanson; F. Anthony Greco; David R 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB

A Phase II Study of Weekly Vinorelbine a

✍ Juan Lucas Bayo-Calero; José I. Mayordomo; Pedro Sánchez-Rovira; Ramón Pérez-Car 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 97 KB